Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2015-11-24 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Deutsche Bank European Corporate Conference
Investor Presentation Classification · 98% confidence The document text is clearly identified as a presentation given at the 'Deutsche Bank European Corporate Conference Tokyo November 24, 2015'. It contains slides detailing the company's portfolio, financial performance (2014 Sales, Q3/15 results), outlook updates, and segment performance. This structure—a slide deck used for investor communication at a conference—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS).
2015-11-24 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managerial role ("Position: Member of a managing body"). The content describes the exercise of stock options and the sale of shares by Dr. Ulf M. Schneider. This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2015-11-20 English
HSBC Healthcare Day
Investor Presentation Classification · 98% confidence The document text explicitly states it is from the "HSBC Healthcare Day, November 12, 2015" and contains numerous slides detailing financial performance, segment breakdowns (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed), outlook updates, and Q3/2015 financial results. This structure, presentation format, and focus on forward-looking statements and segment performance strongly indicate an Investor Presentation (IP) delivered to an external audience (like an investment bank conference). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), which are typically structured differently and filed with the SEC/exchanges. Since it is a presentation for investors, 'IP' is the most appropriate classification.
2015-11-12 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG'. It details a transaction (exercise of stock options and sale) by a 'Member of a managing body' (Dr. Ernst Wastler) of Fresenius SE & Co KGaA. This directly matches the definition for Director's Dealing (DIRS). The document structure and content confirm this classification.
2015-11-05 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG'. It details a transaction (exercise of stock options and sale) by a member of the managing body (Stephan Sturm) involving the company's ordinary shares. This directly matches the definition for Director's Dealing (DIRS). The document length is short, but the content is the primary notification itself, not an announcement of a separate report.
2015-11-04 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction (exercise of stock options and sale of shares) by a person performing managerial responsibilities ("Dr. Jürgen Götz, Member of a managing body"). This directly corresponds to the definition of Director's Dealing (DIRS). The filing mentions section 15a of the WpHG, which governs insider transactions/director dealings in Germany, confirming the classification.
2015-11-04 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.